Skip to Content Accessibility Information

The Office of GOVERNOR LARRY HOGAN

COVID-19 Vaccine Update: March 29, 2021

Maryland providers have administered a total of 2,564,507 COVID-19 vaccines and are averaging a new record-high 49,732 shots per day.

According to the CDC, 37.9% of Maryland’s population age 18 and older has received a vaccine, including 73.9% of Marylanders 65 and older.

1

Official data is posted daily at coronavirus.maryland.gov.

5

  • Phase 2B will begin tomorrow, March 30, and includes Marylanders age 16 and older with underlying medical conditions that increase the risk for severe COVID-19 illness, and Marylanders with disabilities.  Click here to see when you will become eligible.
  • Marylanders in Phase 1, 2A, and 2B eligible populations are now able to pre-register online at covidvax.maryland.gov or by phone through the state’s COVID-19 vaccination support center at 1-855-MD-GOVAX (1-855-634-6829).
  • Pre-registration for two of the six new mass vaccination sites that will be coming online in April: Montgomery College in Germantown and the Maryland State Fairgrounds in Timonium. Pre-registration is available for seven mass vaccination sites, and more sites will be added to pre-registration in the coming days.
  • Hundreds of providers are listed on covidvax.maryland.gov, a one-stop shop for finding providers in your area. Vaccinations are by appointment only.

3

get involved:

In addition to taking the vaccine when it becomes available to you, there are a few ways you can help:

Volunteer at a clinic. Join the Maryland Responds Medical Reserve Corps to support vaccination clinics across the state. Sign up to volunteer at a vaccination clinic.

Join our campaign. The State of Maryland has launched a grassroots public outreach and equity campaign to promote vaccine confidence. These vaccines are safe, effective, and authorized for use by our country’s leading medical experts. Join the GoVAX campaign.

Stay informed. Marylanders are also encouraged to visit covidlink.maryland.gov to review vaccine safety and efficacy information.

Press Release Archives